"GABA Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances used for their pharmacological actions on GABAergic systems. GABAergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function.
| Descriptor ID |
D018682
|
| MeSH Number(s) |
D27.505.519.625.240 D27.505.696.577.240
|
| Concept/Terms |
GABA Agents- GABA Agents
- Agents, GABA
- gamma-Aminobutyric Acid Agents
- Acid Agents, gamma-Aminobutyric
- Agents, gamma-Aminobutyric Acid
- gamma Aminobutyric Acid Agents
- GABAergic Agent
- Agent, GABAergic
- GABAergic Agents
- Agents, GABAergic
GABA Effect- GABA Effect
- Effect, GABA
- GABAergic Effect
- Effect, GABAergic
- GABAergic Effects
- Effects, GABAergic
- GABA Effects
- Effects, GABA
|
Below are MeSH descriptors whose meaning is more general than "GABA Agents".
Below are MeSH descriptors whose meaning is more specific than "GABA Agents".
This graph shows the total number of publications written about "GABA Agents" by people in this website by year, and whether "GABA Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "GABA Agents" by people in Profiles.
-
Repeated methamphetamine administration produces cognitive deficits through augmentation of GABAergic synaptic transmission in the prefrontal cortex. Neuropsychopharmacology. 2022 09; 47(10):1816-1825.
-
Opsoclonus-Myoclonus-Ataxia Syndrome (OMAS) Associated with SARS-CoV-2 Infection: Post-Infectious Neurological Complication with Benign Prognosis. Tremor Other Hyperkinet Mov (N Y). 2021 02 10; 11:7.
-
Oral Agents for the Management of Agitation and Agitated Delirium in Critically Ill Patients. Crit Care Nurs Q. 2017 Oct/Dec; 40(4):344-362.
-
Prenatal cerebral ischemia triggers dysmaturation of caudate projection neurons. Ann Neurol. 2014 Apr; 75(4):508-24.
-
The natural products magnolol and honokiol are positive allosteric modulators of both synaptic and extra-synaptic GABA(A) receptors. Neuropharmacology. 2012 Jun; 62(8):2507-14.
-
RNA editing of the GABA(A) receptor alpha3 subunit alters the functional properties of recombinant receptors. Neurosci Res. 2009 Apr; 63(4):288-93.
-
Layer 2/3 synapses in monocular and binocular regions of tree shrew visual cortex express mAChR-dependent long-term depression and long-term potentiation. J Neurophysiol. 2008 Jul; 100(1):336-45.
-
Safety and efficacy of GABAergic medications for treating alcoholism. Alcohol Clin Exp Res. 2005 Feb; 29(2):248-54.
-
Divalproex loading in the treatment of cocaine dependence. J Psychoactive Drugs. 2001 Jul-Sep; 33(3):283-7.
-
The relationship between substance use disorders, impulse control disorders, and pathological aggression. Am J Addict. 1998; 7(3):221-30.